The rising prevalence of neurological disorders such as schizophrenia and other disorders, the growing geriatric population leading to an increase in brain disorders associated with age, and the applications of the transcranial magnetic stimulation technique in the diagnosis and treatment of neurological disorders are expected to drive the transcranial magnetic stimulators market during the forecast period. However, one of the major constraints in the transcranial magnetic stimulators market during the forecast period is likely to be the scientifically confirmed high efficacy of electroconvulsive therapy in the treatment of psychotic depression and the rising number of patients adopting the therapy. Because of factors such as a large patient population suffering from depression and other psychological and neurological disorders, an increasing number of devices obtaining regulatory approvals, rising demand for new and advanced stimulators, and favourable reimbursement policies, North America is expected to dominate the global transcranial magnetic stimulators market.